Spots Global Cancer Trial Database for anrotinib
Every month we try and update this database with for anrotinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes | NCT05608785 | Gastric Cancer Gastroesophagea... | IBI315 Oxaliplatin Capecitabine TST001 TQB2450 Anrotinib | 18 Years - 75 Years | Henan Cancer Hospital | |
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes | NCT05608785 | Gastric Cancer Gastroesophagea... | IBI315 Oxaliplatin Capecitabine TST001 TQB2450 Anrotinib | 18 Years - 75 Years | Henan Cancer Hospital |